Want to see KR:002020 full AI Analyst Report?
002020 Stock Chart & Stats
$20150.00
-$500.00(-2.42%)
―
--
Day’s Range― - ―
52-Week Range$19,810.00 - $88,200.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)23.49K
Market Cap
₩273.52B
Enterprise Value$3.78T
Total Cash (Recent Filing)₩361.52B
Total Debt (Recent Filing)₩2.80T
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.73%
Share Statistics
EPS (TTM)-4615.27
Shares Outstanding12,907,680
10 Day Avg. Volume31,800
30 Day Avg. Volume23,493
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.48
Price to Sales (P/S)0.14
P/FCF Ratio-10.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5,370
Revenue Forecast (FY)₩6.32T
Bulls Say, Bears Say
Bulls Say
Improving LeverageLower debt-to-equity and a growing equity base provide greater financial flexibility than in 2023. Although leverage remains material, this balance-sheet improvement can support investment across subsidiaries and improve resilience if operating conditions remain difficult.
Pharmaceutical Portfolio ExpansionAdding TONXBIO broadens Kolon’s pharmaceutical platform and increases exposure to drug-development activities through a dedicated subsidiary. The move supports longer-term portfolio diversification and could sharpen the group’s positioning in pharmaceuticals, although contribution remains modest initially.
Subsidiary Project PipelineThe Seoul housing award adds a sizable, multi-year project to Kolon Global’s pipeline and supports future activity in the group’s construction subsidiary. A longer execution period can provide revenue visibility, while the contract’s scale makes it meaningful to the subsidiary’s sales base.
Bears Say
Persistent Cash BurnRepeatedly negative operating and free cash flow indicates that reported business activity is not yet translating into internally generated funding. Continued cash burn can increase reliance on financing or balance-sheet capacity and constrain investment flexibility until operations stabilize.
Volatile ProfitabilityThe swing from strong earlier profits to losses in 2025 and TTM shows limited earnings resilience. Thin operating margins provide little buffer against pressure, while recurring losses weaken return generation and make dependable profitability across the group harder to establish.
Construction Safety And Regulatory RiskThe fatality creates a durable operational and regulatory concern for Kolon Global, a group subsidiary involved in housing projects. Investigation and partial suspension can disrupt execution, increase oversight, and make rigorous safety management important to preserving project continuity.
Kolon Corporation News
002020 FAQ
What was Kolon Corporation’s price range in the past 12 months?
Kolon Corporation lowest stock price was $19810.00 and its highest was $88200.00 in the past 12 months.
What is Kolon Corporation’s market cap?
Kolon Corporation’s market cap is ₩273.52B.
When is Kolon Corporation’s upcoming earnings report date?
Kolon Corporation’s upcoming earnings report date is Nov 18, 2026 which is in 18 days.
How were Kolon Corporation’s earnings last quarter?
Kolon Corporation released its earnings results on Aug 14, 2026. The company reported $1435.891 earnings per share for the quarter.
Is Kolon Corporation overvalued?
According to Wall Street analysts Kolon Corporation’s price is currently Undervalued.
Does Kolon Corporation pay dividends?
Kolon Corporation pays a Annually dividend of $550 which represents an annual dividend yield of 2.73%. See more information on Kolon Corporation dividends here
What is Kolon Corporation’s EPS estimate?
Kolon Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kolon Corporation have?
Kolon Corporation has 12,907,680 shares outstanding.
What happened to Kolon Corporation’s price movement after its last earnings report?
Kolon Corporation reported an EPS of $1435.891 in its last earnings report. Following the earnings report the stock price went down -0.528%.
Which hedge fund is a major shareholder of Kolon Corporation?
Currently, no hedge funds are holding shares in KR:002020
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kolon Corporation
Founded in Gwacheon, South Korea, in 1957, Kolon Corporation operates as a diversified enterprise, primarily supporting and managing its affiliated businesses. Its operations extend to intellectual property licensing, market research, and management consulting, serving both domestic and international markets. The company manufactures a comprehensive range of industrial and chemical products. These include tire cords, airbags, polyester spunbond, technical yarns, aramid products, and various films such as polyester, nylon, and coated films. It also produces DFR materials, overcoats, beads, hydrocarbon, phenolic, and epoxy resins, along with PU/TPU products and glass-reinforced plastic pipes. Additionally, Kolon supplies nylon and polyester fibers, as well as woven, knit, and high-performance functional fabrics. Beyond manufacturing, Kolon is active in commodity trading, dealing in steel, natural resources, and chemicals. Its construction division undertakes residential, industrial plant, civil engineering, and environmental projects. The company also specializes in automotive components, fabricating car seat modules, fabrics, and car mats. Furthermore, it develops specialty fibers like artificial turfs, polypropylene staple fibers, Bicomponent staple fiber, GEONIC, Cuprus, HeaTex, and polyester filaments. Kolon maintains a significant presence in the pharmaceutical and healthcare sectors. It offers over-the-counter medicines, the TRAMOL sustained relief painkiller and anti-inflammatory, active pharmaceutical ingredients, and biopharmaceuticals such as Tissuegene. The company also manages approximately 150 drugstores under the W-Store brand. In real estate and hospitality, Kolon develops properties and manages hotels, condominiums, and golf resorts. Its leisure operations include a shopping mall, a pet theme park, and themed toilets. Further diversifying its portfolio, Kolon operates Sweet Meal cafés, serving pastries, coffee, cheesecakes, and beverages. It supplies antimicrobial products, various PA, PBT, and POM base and compound resins, and retails both hardware and software. The company also delivers IT and business process outsourcing, alongside IT convergence services. Finally, Kolon is deeply involved in water-related environmental businesses, covering sewage and wastewater treatment, including the provision of materials, systems, equipment, and the operation of water treatment facilities. It also runs an industrial supply retail operation.
Technical Analysis
Hyosung Corporation
―
SK Discovery Co. Ltd.
―
POSCO INTERNATIONAL Corporation
―
KPX Holdings Co., Ltd.
―
Samyang Corporation
―



